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Abstract Rectal cancer is an increasing problem in the developing world. There is
little written on how to manage this problem outside the confines of major teaching
hospitals in Western Countries. In these centres debate surrounds preoperative
staging, the use of preoperative radiotherapy and sophisticated sphincter preserv-
ing procedures. The literature is complex and of little relevance to those faced with
a patient with rectal cancer in rural Africa or Asia far from the ivory towers.
This review aims to combine the best of evidence based medical practice related
to the management of rectal cancer with the practical realities of operating in
resource poor environments.
In this situation staging is by means of simple radiology and a clinical examination
supplemented by an examination under anaesthetic. If there are no distant metas-
tases and the tumour is freely mobile a resection can be attempted. An abdomino-
perineal resection is a good operation with a proven track record. If an anastomosis
can be fashioned then an anterior resection is an excellent operation and should be
performed extrafascially to avoid local recurrence. It is vital to counsel the patient
preoperatively. The pros and cons of referral to a centre of excellence need to be
discussed with the patient prior to any intervention.
ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Rectal cancer is an increasing problem in the
developing world.1e4 Although not yet common it
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ease is advanced at presentation and therefore
difficult to manage.5 There is little written on
how to manage this problem outside the confines
of major teaching hospitals in Western Coun-
tries.6,7 In these centres debate surrounds pre-
operative staging, the use of preoperative
radiotherapy and sophisticated sphincter preserv-
ing procedures. The literature is complex and of
little relevance to those faced with a patientlished by Elsevier Ltd. All rights reserved.
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the ivory towers.
This review aims to combine the best of evi-
dence based medical practice related to the
management of rectal cancer with the practical
realities of operating in resource poor environ-
ments. By this we mean those places where
sophisticated imaging and adjuvant oncological
facilities are either absent or difficult to access.
This is not to say that there are not such facilities
in the developing world but rather to address the
issues as they are for the majority of surgeons in
the developing world.
Staging and neoadjuvant radiotherapy
Preoperative staging is generally accepted as being
of great importance in the management of rectal
cancer. This is because of the recognition that
preoperative radiotherapy decreases the risk of
local recurrence by about 50% in patients with
locally advanced tumours.8 However, there remains
debate in the literature regarding optimal use of
preoperative radiotherapy and chemotherapy.9
While it is generally agreed that radiotherapy
should be given preoperatively rather than postop-
eratively if possible,10,11 predicting which patients
will benefit from neoadjuvant therapy is a subject
of great debate. The debate surrounds predicting
which patients are likely to be node positive and
in which patients it will be difficult to achieve
a clear circumferential margin, this being a key
factor in prevention of local recurrence.12 The
gold standards for local staging are endoanal ultra-
sonography and magnetic resonance imaging.13e16
It is unlikely that these modalities are easily acces-
sible to patients in the developing world if only for
financial reasons.
Without these modalities, potential resectabil-
ity (with a clear circumferential margin) is assess-
able by an examination under anaesthetic.17
Accuracy ranges from 44 to 83% and increases
with experience.14 If the tumour is fixed then it
is best judged as not resectable and consideration
needs to be given as to the best way in which pal-
liation may be achieved. If the tumour is tethered
or freely mobile then the best management is
probably an attempt at resection. Due to difficul-
ties with access to radiotherapy it is difficult to
recommend preoperative radiotherapy outside
major centres where this is readily available and
the machines are capable of delivering the radia-
tion dose precisely.
Consideration then needs to be given to staging
of metastatic disease. Most hospitals wheresurgery is performed have access to ultrasonogra-
phy and chest X-rays and these are reliable
methods of assessing the presence or absence of
liver and lung metastases. Unless the patient is
very symptomatic from the rectal cancer it would
be unwise to attempt resection in a patient with
a heavy burden of metastatic disease.18 If it is
thought necessary to operate then a well formed
end stoma is probably the safest option in a patient
with a limited life span unless the operation can be
confidently and safely performed without need for
a defunctioning stoma.
Operative treatment
Given that the surgeon in a resource poor environ-
ment is unlikely to have access to neoadjuvant
therapy then the only weapon in the armamentar-
ium is a good operation. In the West the standard of
care is a total mesorectal excision of the rectum
with a double stapled anastomosis.19 Interestingly
some doubt regarding the wisdom of this approach
has been raised in recent years especially with very
low anastomoses. It has been demonstrated that
the quality of life following an abdominoperineal
resection of the rectum (APR) is similar to that
following a low anterior resection.20,21 A stoma is
probably associated with a decreased quality of
life in the developing world but it may well be bet-
ter than a very poorly functioning anastomosis.22
Alternatively, a low anterior resection with
a handsewn coloanal anastomosis is a cheap and
oncologically sound option. Others have described
an intersphincteric perineal dissection and coloa-
nal anastomosis although this is associated with
a worse quality of life than a conventional
anastomosis.23
Although there is a thought that stomas are
taboo in the developing world our experience is
that this is not the case. Relatively high rates of APR
from specialised centres in the developing world
would suggest that stomas are acceptable if rea-
sonable stoma care is available.6 With appropriate
counselling and reasonable stoma care in the hospi-
tal prior to discharge many patients do very well.
There are certain absolute contraindications to
a low anastomosis. The most important one, other
than the ability to achieve clear margins, is a poorly
functioning anal sphincter mechanism. There are
very sophisticated methods of measuring sphincter
function but a surgeon performing a rectal exam-
ination is probably as accurate and it is generally
true that the presence of good preoperative
continence is the best indicator of postoperative
continence after an anterior resection.24,25
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ineal wound and may be the most appropriate
procedure in selected patients.26 However, it is
not the perfect alternative to the APR as there is
a very high pelvic collection rate after this
procedure.27
There remains debate over the best stoma for
those patients who are defunctioned, the choice
being between a loop ileostomy or a loop trans-
verse colostomy.28,29 If surgery does necessitate
a defunctioning stoma this can be closed at 10
days postoperatively if there are no complications
and a contrast study shows no leak.30 If a contrast
study is not available then the stoma can be closed
at 6 weeks postoperatively without the contrast
study if the postoperative course is uneventful
and the anastomosis is normal on clinical
examination.31
It has become clear over the last century that
the best operation for rectal cancer is an extra-
fascial excision of the rectum.32,33 In many centres
this is known as a total mesorectal excision (TME)
but for cancers of the upper rectum a resection
less than a total mesorectal excision can be per-
formed where the mesorectum is dissected in the
extrafascial plane and is divided at least 5 cm
below the tumour and the anastomosis fashioned
in the mid rectum. The surgeon needs to take par-
ticular care posteriorly to dissect outside the fas-
cia propria of the rectum through areolar tissue
between this and the presacral fascia. At the pel-
vic brim care needs to be taken with the pelvic au-
tonomic nerves and anteriorly it is probably easiest
to stay behind Denonvillier’s fascia. If the tumour
is found to be breaching fascial planes then an
anastomosis seems unwise as local recurrence
is likely and this could lead to obstruction in the
future. A well fashioned stoma at this stage is
perhaps easier to live with. Postoperative radio-
therapy, if available, may well be appropriate in
this situation.
It is of course important to be aware of the
possibility of a synchronous colonic cancer and if
preoperative colonoscopy or barium enema is not
available a thorough examination of the colon at
laparotomy is mandatory.
The role of referral to a centre of
excellence
Each surgeon needs to ask himself what is best for
the individual patient. There is clear evidence
from Western Centres that rectal cancer is best
managed by surgeons who perform large numbers
of operations for this condition in hospitals wheremultidisciplinary teams work together to provide
optimal care for patients.34e37 If it is possible to
refer the patient to such a centre this would be
wise. This decision is often very difficult to make
and a second opinion is advisable in this situation.
An appropriate discussion with the patient regard-
ing the pros and cons of referral to a centre of
excellence will need to be entered into.
Conclusions
In this paper we have attempted to provide
a rationale for management of a patient with
a rectal cancer presenting to a surgeon in a re-
source poor environment. In this situation staging
is by means of simple radiology and a clinical
examination supplemented by an examination
under anaesthetic. If there are no distant metas-
tases and the tumour is freely mobile a resection
can be attempted. One option for very low
tumours is an ultralow Hartmann’s procedure
avoiding the complications of a perineal wound.
Otherwise an APR is a good operation with a proven
track record. If an anastomosis can be fashioned
then an anterior resection is an excellent opera-
tion and should be performed extrafascially to
avoid local recurrence.
It is vital to counsel the patient preoperatively.
The pros and cons of referral to a centre of
excellence need to be discussed with the patient
prior to any intervention.
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